4
Clinical Trials associated with ScTIL210An Open-label, Single-arm, Single-dose Escalation and Multiple-dose Expansion Clinical Study of Cell Therapy to Evaluate the Tolerance, the Pharmacokinetic Characteristics, the Safety, and the Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors
An open-label, single-arm, single-dose escalation and multiple-dose expansion clinical study of cell therapy to observe and to evaluate the tolerance, the pharmacokinetic characteristics, the safety, and the efficacy of ScTIL210 in the treatment of malignant
An open-label, single-arm, single-dose escalation and multiple-dose expansion clinical study of cell therapy to observe and to evaluate the tolerance, the pharmacokinetic characteristics, the safety, and the efficacy of ScTIL210 in the treatment of malignant solid tumors
Start Date01 Aug 2020 |
Sponsor / Collaborator- |
An open-lable, single-arm, single-dose escalation and multiple-dose expansion clinical study of cell therapy to observe and evaluate the tolerance, pharmacokinetic characteristics, safety and efficacy of ScTIL210 in the treatment of Melanoma
Start Date04 May 2020 |
Sponsor / Collaborator- |
100 Clinical Results associated with ScTIL210
100 Translational Medicine associated with ScTIL210
100 Patents (Medical) associated with ScTIL210
100 Deals associated with ScTIL210